Ionis Pharmaceuticals (IONS) Invested Capital (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Invested Capital of $432.5 million for Q1 2026, little changed quarter-over-quarter from $431.9 million in Q4 2025.
Ionis Pharmaceuticals (IONS) Invested Capital (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Invested Capital history runs 17 years deep, the most recent figure standing at $432.5 million for Q1 2026.
- In Q1 2026, Invested Capital changed N/A year-over-year to $432.5 million; the TTM figure through Jun 2026 stood at $1.5 billion (up 121.67% YoY), while the FY2025 annual figure was $431.9 million, changed N/A from the prior year.
- Invested Capital for Q1 2026 stood at $432.5 million, roughly flat from $431.9 million in the prior quarter.
- The five-year high for Invested Capital was $630.9 million in Q3 2025, with the low at $4.2 million in Q1 2022.
- The 5-year median for Invested Capital is $44.4 million (2024), against an average of $210.6 million.
- The sharpest annual moves came in 2022 and 2025: Invested Capital slumped 93.2% in 2022, then jumped 1318.83% in 2025.
- Ionis Pharmaceuticals' Invested Capital stood at $5.0 million in 2022, then surged by 791.99% to $44.3 million in 2023, then climbed by 0.3% to $44.5 million in 2024, then soared by 871.39% to $431.9 million in 2025, then grew by 0.13% to $432.5 million in 2026.
- Business Quant data shows IONS's Invested Capital at $432.5 million in Q1 2026, $431.9 million in Q4 2025, and $630.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 432.50 Mn |
| Dec 31, 2025 | 431.95 Mn |
| Sep 30, 2025 | 630.91 Mn |
| Jun 30, 2025 | 630.12 Mn |
| Sep 30, 2024 | 44.47 Mn |
| Jun 30, 2024 | 44.42 Mn |
| Mar 31, 2024 | 44.38 Mn |
| Dec 31, 2023 | 44.33 Mn |
| Sep 30, 2022 | 4.97 Mn |
| Jun 30, 2022 | 4.73 Mn |
| Mar 31, 2022 | 4.21 Mn |
| Dec 31, 2021 | 3.53 Mn |
| Sep 30, 2021 | 61.94 Mn |
| Jun 30, 2021 | 61.88 Mn |
| Mar 31, 2021 | 61.82 Mn |
| Dec 31, 2020 | 308.81 Mn |
| Sep 30, 2020 | 5.85 Mn |
| Jun 30, 2020 | 4.97 Mn |
| Mar 31, 2020 | 4.15 Mn |
| Sep 30, 2019 | 2.06 Mn |